RENAL 1,25‐DIHYDROXYVITAMIN D, PHOSPHATURIC, AND CYCLIC‐AMP RESPONSES TO INTRAVENOUS SYNTHETIC HUMAN PARATHYROID HORMONE‐(1‐34) ADMINISTRATION IN NORMAL SUBJECTS
David M. Slovik(Boston University), Robert M. Neer(Brigham and Women's Hospital), John T. Potts(National Institutes of Health), Margaret A. Daly(Harvard University)
Cited by 11
Related Papers
Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
|The Lancet|2015|574
Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
|The Lancet|2013|491
Deficient Production of 1,25-Dihydroxyvitamin D in Elderly Osteoporotic Patients
|New England Journal of Medicine|1981|372
Decreased Bone Density in Hyperprolactinemic Women
|New England Journal of Medicine|1980|363